Skip to content

Online group cognitive behavioural therapy for South African university students with depression and anxiety

A randomised controlled trial of an online group cognitive behavioural therapy intervention for South African students with depression and anxiety

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47089643
Enrollment
210
Registered
2023-10-11
Start date
2022-08-17
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild-to-moderate symptoms of depression and anxiety Mental and Behavioural Disorders

Interventions

The trial will take place across between three and five of the following universities: Stellenbosch University (SU), the University of the Free State (UFS), the University of Cape Town (UCT), the Univ

Sponsors

Stellenbosch University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Enrolled as an undergraduate student at one of the target institutions 3. Provide Informed Consent 4. Access to the internet to join the online group 5. Report mild-to-moderate symptoms of depression and/or anxiety (taken as a symptom threshold of 10 or above on both scales)

Exclusion criteria

Exclusion criteria: 1. No internet availability 2. Students who report active suicidality with intent will be referred to appropriate campus-based crises services, national suicide helplines, and any additional referral sites specified by the local administration 3. Students who do not have at least mild-to-moderate symptoms of depression and/or anxiety will also be excluded but given advice about how to access informational resources about mental health, and will not be followed up

Design outcomes

Primary

MeasureTime frame
Self-reported depression and anxiety symptoms measured using the Patient Health Questionnaire-9 (PHQ-9) and the Generalised Anxiety Disorder Assessment (GAD-7) at baseline, 3, 6 and 12 months

Secondary

MeasureTime frame
1. Attention and concentration: Standardised survey instrument to measure attention and concentration from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 2. Substance use: Standardised survey instrument to measure substance use from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 3. Panic attacks: Standardised survey instrument to measure symptoms of panic from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 4. Social anxiety: Standardised survey instrument to measure symptoms of social anxiety from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 5. High mood: Standardised survey instrument to measure symptoms of high mood (or ‘mania’) from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 6. Obsessive-compulsive disorder: Standardised survey instrument to measure symptoms of obsessive-compulsive disorder from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 7. Stressful experiences: Standardised survey instrument to measure symptoms of PTSD and exposure to stressful life events from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 8. Other behavioural health problems: Standardised survey instrument to measure symptoms of disordered eating and dissociation from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months 9. Self-harm: Standardised survey instrument to assess the presence of self-harm behaviours and suicidality from The Composite International Diagnostic Interview Screening Scales (CIDI-SC) at baseline, 3, 6 and 12 months

Countries

South Africa

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026